Mammography News and Research RSS Feed - Mammography News and Research

A mammogram is a safe test used to look for any problems with a woman's breasts. The test uses a special, low-dose x-ray machine to take pictures of both breasts. The results are recorded on x-ray film or directly onto a computer for a radiologist to examine.

Mammograms allow the doctor to have a closer look for breast lumps and changes in breast tissue. They can show small lumps or growths that a doctor or woman may not be able to feel when doing a clinical breast exam. "Mammography" is the best screening tool that doctors have for finding breast cancer.

If a lump is found, your doctor may order other tests, such as ultrasound or a biopsy--a test where a small amount of tissue is taken from the lump and area around the lump. The tissue is sent to a lab to look for cancer or changes that may mean cancer is likely to develop. Breast lumps or growths can be benign (not cancer) or malignant (cancer). Finding breast cancer early means that a woman has a better chance of surviving the disease. There are also more choices for treatment when breast cancer is found early.
OU and Mercy receive $2.5 million grant to develop new short-term breast cancer risk prediction models

OU and Mercy receive $2.5 million grant to develop new short-term breast cancer risk prediction models

The University of Oklahoma and Mercy Hospital Oklahoma City are developing new short-term breast cancer risk prediction models that aim to help increase cancer detection of breast magnetic resonance imaging screening. [More]
UT System Board of Regents approves new UT Southwestern Monty and Tex Moncrief Medical Center

UT System Board of Regents approves new UT Southwestern Monty and Tex Moncrief Medical Center

The University of Texas System Board of Regents has approved establishment of the UT Southwestern Monty and Tex Moncrief Medical Center at Fort Worth, made possible by an extraordinary $25 million commitment from W.A. "Tex" Moncrief Jr. The Center is UT Southwestern's first named campus outside of Dallas. [More]
Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod. [More]
Researchers refine breast cancer risk model to give more accurate assessment

Researchers refine breast cancer risk model to give more accurate assessment

A national risk model that gauges a woman's chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than one million patients, reveal a 300 percent increase in a subset of women whose five-year risk is estimated at 3 percent or higher. [More]
Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women with dense breast tissue

Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women with dense breast tissue

A recent study conducted by Mayo Clinic has determined that the addition of Molecular Breast Imaging (MBI) for women with dense breast tissue resulted in a lower cost per cancer detected than screening with mammography alone. [More]
Swarm intelligence can help to improve breast cancer screening

Swarm intelligence can help to improve breast cancer screening

Breast cancer is the most frequent type of cancer in women and currently accounts for 29% of all new cancer cases in the U.S. Wide-ranging mammography screening programs have been set up for early diagnosis. However, even if two physicians assess the x-rays, which is the usual procedure in Europe, this often leads to wrong decisions: about 20% of patients with cancer are diagnosed as being cancer-free, whereas about 20% of cancer-free patients are diagnosed with cancer. [More]
BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

The BRCA gene encodes for the BRCA proteins, BRCA1 and BRCA2. These proteins are very important in repairing DNA, which they do by correcting double-stranded breaks. [More]
Pantheon announces acquisition of IBSL

Pantheon announces acquisition of IBSL

Pantheon Holdco Ltd., doing business as the Pantheon Healthcare Group, announced today the acquisition of Ingegneria Biomedica Santa Lucia S.p.A., a key Italian-based provider of Clinical Engineering and a large range of biomedical equipment services, from Gruppo Giglio. [More]
New public guide addresses unrealistic expectations of screening tests

New public guide addresses unrealistic expectations of screening tests

Misconceptions about how screening works, its limitations and possible harms are still being perpetuated by media stories and high profile cases, such as Angelina Jolie's double mastectomy and emotive tabloid case studies of women under 25 dying from cervical cancer. [More]

Cancer Council Queensland urges women to be breast aware between scheduled screenings

Hundreds of Queensland women are developing breast cancers between screening each year, prompting a warning from Cancer Council for women to be breast aware between mammograms. [More]
High breast density can impact cancer screening methods

High breast density can impact cancer screening methods

When it comes to breast cancer screening, the density of your breasts affects how well a mammogram can detect cancerous tissues. That's why Pennsylvania and 20 other states have adopted laws requiring radiologists to include information about breast density in every woman's mammogram report. [More]
Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

Actavis plc, which recently completed the acquisition of Allergan, Inc., today announced that the company has received approval from the U.S. Food and Drug Administration to market NATRELLE INSPIRA round gel-filled textured breast implants, offering women undergoing reconstruction, augmentation or revision surgery another breast shaping option for a customized result. [More]
Researchers call for improving screening accuracy to reduce false-positive mammograms

Researchers call for improving screening accuracy to reduce false-positive mammograms

The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine. [More]

Many U.S. adults not undergoing recommended screenings for colorectal, breast and cervical cancers

Many adults in the U.S. are not getting the recommended screening tests for colorectal, breast and cervical cancers, according to data published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report. For 2013, screening for these types of cancers either fell behind previous rates or showed no improvement. [More]
Tomosynthesis detects more breast cancers compared to traditional mammography

Tomosynthesis detects more breast cancers compared to traditional mammography

Tomosynthesis detects 40% more breast cancers than traditional mammography does, according to a major screening study from Lund University, Sweden. This is the first large-scale study to compare the screening method with regular mammograms. The 3D X-ray technique is also more comfortable for women, as breast compression is halved. [More]
UC Davis professor awarded $2.88 million NCI grant for breast CT research and development

UC Davis professor awarded $2.88 million NCI grant for breast CT research and development

John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer. [More]
Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Ikonopedia's breast imaging reporting tools, MQSA management system selected for use by BelleBridge

Ikonopedia announced today that its breast imaging reporting tools and MQSA management system have been selected for use by BelleBridge, which provides telemedicine services for interpretations of breast screening and diagnostic examinations. [More]
Nonprofit group launches website that provides education, information about breast density

Nonprofit group launches website that provides education, information about breast density

Recognizing that both women and their doctors are often confused after a mammogram reveals the woman has dense breasts, a nonprofit organization has launched a major new educational website. The site, www.DenseBreast-info.org, addresses questions women and their healthcare providers often have about breast density - helping them to "Get Smart about Being Dense." [More]
New metabolic blood profile method could help predict breast cancer

New metabolic blood profile method could help predict breast cancer

According to the World Health Organization, breast cancer is the most common cancer in women both in the developed and less developed world, and in the long term the scientists hope that the new method will lead to better prevention and early treatment of the disease. [More]
Around 90% of all breast cancers can be diagnosed using MRI, shows study

Around 90% of all breast cancers can be diagnosed using MRI, shows study

Around 90 per cent of all breast cancers can be definitively diagnosed using magnetic resonance imaging (MRI). This compares to the combined methods of mammography and ultrasound which yielded a detection rate of just 37.5 per cent. [More]
Advertisement
Advertisement